Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JY016 in Advanced Solid Tumors Expressing EGFR
NCT07510841Phase 2Recruiting
- Start
- May 2026
- Primary completion
- May 2029
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of JY016 in solid tumor. Started May 2026; status: recruiting.
02
Drugs
JY016
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07510841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07510841.